Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Foglietta

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Lung Cancer (Amsterdam, Netherlands)|October 24, 2006
Development of new first-line therapeutic options for non-small-cell lung cancerLucio Crinò, Jennifer Foglietta, Alketa Hamzaj
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 26, 2007
Lung cancerLucio Crinò, Jennifer Foglietta, Alketa Hamzaj
Seminars in Cancer Biology|November 13, 2017
Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapyBiagio Ricciuti, Jennifer Foglietta, Vanessa Bianconi, et al.
Giornale Italiano Di Cardiologia (2006)|March 28, 2022
[Hormone therapy, cardio-metabolic profile and cardiotoxicity. Still a dark side of cardio-oncology. Part 1: Breast cancer]Luigi Tarantini, Jennifer Foglietta, Stefania Gori, et al.
Medical Oncology (Northwood, London, England)|December 7, 2017
Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applicationsBiagio Ricciuti, Jennifer Foglietta, Rita Chiari, et al.
Giornale Italiano Di Cardiologia (2006)|May 18, 2013
[Heart failure in women treated with adjuvant trastuzumab for breast cancer]Luigi Tarantini, Mauro Feola, Adriana Albini, et al.
Tumori|May 23, 2022
Adherence to oral hormonal anticancer agents in breast cancerStefania Gori, Alessandra Modena, Jennifer Foglietta, et al.
Giornale Italiano Di Cardiologia (2006)|September 28, 2023
[Hormone therapy, cardio-metabolic profile, and cardiotoxicity. Still a dark side of cardio-oncology - Part 2: Prostate cancer]Luigi Tarantini, Stefania Di Girolamo, Cristina Masini, et al.
Clinical Breast Cancer|August 27, 2016
Cardiotoxicity of Aromatase Inhibitors in Breast Cancer PatientsJennifer Foglietta, Alessandro Inno, Francesca de Iuliis, et al.
Tumori|February 8, 2014
Sunitinib therapy in metastatic papillary thyroid cancerStefania Gori, Jennifer Foglietta, Marta Rossi, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Lung Cancer (Amsterdam, Netherlands)|October 24, 2006
Development of new first-line therapeutic options for non-small-cell lung cancerLucio Crinò, Jennifer Foglietta, Alketa Hamzaj
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 26, 2007
Lung cancerLucio Crinò, Jennifer Foglietta, Alketa Hamzaj
Seminars in Cancer Biology|November 13, 2017
Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapyBiagio Ricciuti, Jennifer Foglietta, Vanessa Bianconi, et al.
Giornale Italiano Di Cardiologia (2006)|March 28, 2022
[Hormone therapy, cardio-metabolic profile and cardiotoxicity. Still a dark side of cardio-oncology. Part 1: Breast cancer]Luigi Tarantini, Jennifer Foglietta, Stefania Gori, et al.
Medical Oncology (Northwood, London, England)|December 7, 2017
Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applicationsBiagio Ricciuti, Jennifer Foglietta, Rita Chiari, et al.
Giornale Italiano Di Cardiologia (2006)|May 18, 2013
[Heart failure in women treated with adjuvant trastuzumab for breast cancer]Luigi Tarantini, Mauro Feola, Adriana Albini, et al.
Tumori|May 23, 2022
Adherence to oral hormonal anticancer agents in breast cancerStefania Gori, Alessandra Modena, Jennifer Foglietta, et al.
Giornale Italiano Di Cardiologia (2006)|September 28, 2023
[Hormone therapy, cardio-metabolic profile, and cardiotoxicity. Still a dark side of cardio-oncology - Part 2: Prostate cancer]Luigi Tarantini, Stefania Di Girolamo, Cristina Masini, et al.
Clinical Breast Cancer|August 27, 2016
Cardiotoxicity of Aromatase Inhibitors in Breast Cancer PatientsJennifer Foglietta, Alessandro Inno, Francesca de Iuliis, et al.
Tumori|February 8, 2014
Sunitinib therapy in metastatic papillary thyroid cancerStefania Gori, Jennifer Foglietta, Marta Rossi, et al.
Pageof 4